Merck & Co. said Tuesday new data from a late-stage study showed its allergy treatment candidate met key effectiveness goals when compared with placebo. The company said patients treated with its sublingual grass, or Phleum Pratense, allergy immunotherapy tablet showed a 26 percent greater improvement in allergy symptoms than patients on ...

WASHINGTON (Reuters) - Sneezing, congestion, and runny noses from hay fever may be lasting longer because climate change may be extending pollen seasons, doctors in Italy said on Monday. Pollen seasons as well as the amount of pollen in the air progressively increased during a 26-year study in Italy, the doctors told a meeting of the American Academy of Allergy, Asthma ...

LONDON (Reuters) - Scientists have identified new genetic links to celiac disease and say their findings could speed the search for better ways to diagnose and treat the gluten-intolerance disorder. British researchers scanned the genetic maps of more than 9,400 celiac patients and found areas of immune system disturbance which lead to the development of the auto-immune disease, which affects ...

WASHINGTON (Reuters) - Eating meat may be a much more common trigger for anaphylaxis -- a severe and potentially deadly allergic reaction -- than previously thought, U.S. researchers said on Sunday. A study of 60 patients who had unexplained severe allergic reactions suggests that a compound in meat known as alpha-galactose may be the culprit, according to research presented at a meeting ...